Efficacy and safety of canagliflozin when used in conjunction with incretin‐mimetic therapy in patients with type 2 diabetes - Concepedia

Concepedia

Publication | Closed Access

Efficacy and safety of canagliflozin when used in conjunction with incretin‐mimetic therapy in patients with type 2 diabetes

91

Citations

18

References

2015

Year

Gregory Fulcher, David R. Matthews, Vlado Perkovic, Dick de Zeeuw, Kenneth W. Mahaffey, Chantal Mathieu, Vincent Woo, Carol Wysham, George Capuano, Mehul Desai,

Diabetes Obesity and Metabolism

Abstract

In patients on background incretin mimetics, canagliflozin improved HbA1c, body weight and BP, with an increased incidence of AEs related to SGLT2 inhibition.

References

	Year	Citations

Page 1